Extrafollicular and follicular B cell activation by SARS-CoV-2 (WP5218)
Homo sapiens
The pathway model depicts the initial B cell activation inside the lymph node and the following activation routes to differentiate to either plasmablast cells following the extrafollicular pathway or memory B cells through the follicular pathway. Detailed pathway description and its application for data visualization can be found in this preprint doi: https://doi.org/10.1101/2022.12.19.521064
Authors
Nuray Talih , Alex Pico , Egon Willighagen , Nhung Pham , John Figueira Hasbun , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
COVID-19Annotations
Cell Type Ontology
macrophage plasmablast dendritic cell memory B cell follicular B cell T cellDisease Ontology
severe acute respiratory syndrome COVID-19Pathway Ontology
signaling pathway disease pathway B cell receptor signaling pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
α-GalCer | Metabolite | cas:158021-47-7 | α-galactosylceramide |
FcRL5 | GeneProduct | ensembl:ENSG00000143297 | |
CD22 | GeneProduct | ensembl:ENSG00000012124 | |
IRF4 | GeneProduct | ensembl:ENSG00000137265 | Induction of high concentration of IRF4 after B cell activation drives the rapid generation of plasmablasts. On the contrary, low concentrations of IRF4 may enable sustained expression of AID, CSR, and GC B cell response. |
IFIT2 | GeneProduct | ensembl:ENSG00000119922 | |
IFITM1 | GeneProduct | ensembl:ENSG00000185885 | |
CD80 | GeneProduct | ensembl:ENSG00000121594 | |
PRDM1 | GeneProduct | ensembl:ENSG00000057657 | |
IRF8 | GeneProduct | ensembl:ENSG00000140968 | IRF8 dampens signaling via BCR and facilitates antigen-specific interaction with T helper cells. It also promotes antibody affinity maturation while antagonizing IRF4 driven differentiation of plasmablasts. High IRF8:IRF4 ratio promotes GC differentiation. |
CXCL12 | GeneProduct | ensembl:ENSG00000107562 | CXCL12 is expressed in the medullary cords of the lymph nodes and in the bone marrow. |
PD1 | GeneProduct | ensembl:ENSG00000188389 | PDCD1/PD1 |
ISG15 | GeneProduct | ensembl:ENSG00000187608 | ISG15 acts as a chemoattractant for neutrophils. PBs that secrete ISG15 are a proinflammatory feature in autoimmune diseases like SLE. |
CRP | GeneProduct | ensembl:ENSG00000132693 | C-reactive protein (CRP), an acute phase reactant in the IL-6 pathway commonly used as a biomarker of COVID-19 severity. |
BLNK | GeneProduct | ensembl:ENSG00000095585 | |
CD69 | GeneProduct | ensembl:ENSG00000110848 | Upon encounter with their cognate antigen, B cells rapidly upregulate CD69. CD69 is an inhibitor the lymphoid egress , mediating receptor S1P1 and resulting in secondary lymphoid organ retention. |
SLAMF7 | GeneProduct | ensembl:ENSG00000026751 | |
XBP1 | GeneProduct | ensembl:ENSG00000100219 | X-box binding protein-1 (XBP-1) is esssential for plasma cell differentiation. |
IL-10 | GeneProduct | ensembl:ENSG00000136634 | |
SYK | GeneProduct | ensembl:ENSG00000165025 | |
Blimp1 | GeneProduct | ensembl:ENSG00000057657 | PRDM1/Blimp1 |
CD19 | GeneProduct | ensembl:ENSG00000177455 | |
ZEB2 | GeneProduct | ensembl:ENSG00000169554 | ZEB2 is a transcription factor that is highly expressed in DN2 cells and aNAV cells. ZEB2 cooperatively acts with T-bet to promote effector differentiation and inhibit memory differentiation in cytotoxic T cells. |
TBET | GeneProduct | ensembl:ENSG00000073861 | TBX21/TBET is expressed in high amounts by DN2 B cells but also aNAV. |
APRIL | GeneProduct | ensembl:ENSG00000161955 | TNFSF13/APRILstimulates AID induction independently of CD40. |
PTPRC | GeneProduct | ensembl:ENSG00000081237 | CD45 |
CD11c | GeneProduct | ensembl:ENSG00000140678 | DCs in the medullary cords or the T zone of the lymph nodes express high amounts of CD11c. CD11c forms a heterodimer with CD18 |
NEAT1 | GeneProduct | ensembl:ENSG00000245532 | |
PAX5 | GeneProduct | ensembl:ENSG00000196092 | PAX5 is a dual function activator and suppressor and is required for germinal center formation. PAX5 along with Bach2 and Bcl6 stabilize The GC B cell state while antagonizing plasma cell differntiation. |
XBP1 | GeneProduct | ensembl:ENSG00000100219 | |
FOXO1 | GeneProduct | ensembl:ENSG00000150907 | Transcription factor FOXO1 inhibits T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. |
CR1 | GeneProduct | ensembl:ENSG00000203710 | CR1 (CD35) |
CCL19 | GeneProduct | ensembl:ENSG00000172724 | |
CD18 | GeneProduct | ensembl:ENSG00000160255 | |
TMSB10 | GeneProduct | ensembl:ENSG00000034510 | gene TMSB10 is Pax5-repressed |
IFNG-AS1 | GeneProduct | ensembl:ENSG00000255733 | |
HSPA8 | GeneProduct | ensembl:ENSG00000109971 | associated with metabolic processes and autophagy |
BACH2 | GeneProduct | ensembl:ENSG00000112182 | Stabilizes GC B cells while aantagonizing plasma cell differeentiation. |
CCL21 | GeneProduct | ensembl:ENSG00000137077 | |
MS4A1 | GeneProduct | ensembl:ENSG00000156738 | MS4A1/CD20 |
IGHV4-34 | GeneProduct | ensembl:ENSG00000211956 | |
BAFF | GeneProduct | uniprot:Q9Y275 | B cell activating factor (BAFF) |
EBI3 | GeneProduct | ensembl:ENSG00000105246 | |
ETS1 | GeneProduct | ensembl:ENSG00000134954 | DN2 B cells and aNAV B cells express the lowest amounts of ETS1. ETS1 inhibits PC differentiation. Deficiency of ETS1 may cause extrafollicular accumulation of autoreactive plasma cells. |
CD79A | GeneProduct | ensembl:ENSG00000105369 | |
CD82 | GeneProduct | ensembl:ENSG00000085117 | |
IL-2 | GeneProduct | ensembl:ENSG00000109471 | |
PTCRA | GeneProduct | ensembl:ENSG00000171611 | Pre T-cell antigen receptor alpha, pT-alpha, pTa (pT-alpha-TCR) |
CD40 | GeneProduct | ensembl:ENSG00000101017 | |
IL-6 | GeneProduct | ensembl:ENSG00000136244 | IL-6 mainly promotes differentiation of antigen-specific B cells to plasmablasts. |
BCL6 | GeneProduct | ensembl:ENSG00000113916 | transcription factor; critical regulator of Tfh differentiation. Lack of Bcl6 in CD4+T cells leads to inability to differentiate into Tfh cells. |
CXCR5 | GeneProduct | ensembl:ENSG00000160683 | |
TLR7 | GeneProduct | ensembl:ENSG00000196664 | |
STAT5A | GeneProduct | ensembl:ENSG00000126561 | |
BCR | GeneProduct | ensembl:ENSG00000186716 | |
PD1 | GeneProduct | ensembl:ENSG00000188389 | inhibitory receptor |
c-Maf | GeneProduct | uniprot:O75444 | musculoaponeurotic fibrosarcoma (c-Maf) |
ICOS | GeneProduct | ensembl:ENSG00000163600 | |
TLR4 | GeneProduct | ensembl:ENSG00000136869 | |
IL12 | GeneProduct | ensembl:ENSG00000168811 | IL-12 regulates humoral immunity by strongly inhibiting TFH differentiation. In vitro, it induces IFNγ and IL-21 in human T cells. (IL12A) |
IL-4 | GeneProduct | ensembl:ENSG00000113520 | |
CXCR5 | GeneProduct | ensembl:ENSG00000160683 | the chemokine receptor CXCR5 is increasingly expressed upon follicle entry via the CXCL13 gradient. |
Blimp1 | GeneProduct | ensembl:ENSG00000057657 | PRDM1/Blimp-1 (B lymphocyte-induced maturation protein-1): Upregulation of Blimp-1 expression is associated with plasmablast differentiation. |
BCL6 | GeneProduct | ensembl:ENSG00000113916 | Follicular pathway leads to Bcl6-expressing germinal center B cells known as centroblasts and centrocytes. Bcl6 is a transcriptional repressor that inhibits the diffenertiation towarrds plasmablasts by repressing Blimp1 |
CD35 | GeneProduct | ensembl:ENSG00000203710 | CD35 or CR1 |
CD21 | GeneProduct | ensembl:ENSG00000117322 | CR2 or CD21 |
MFGE8 | GeneProduct | ensembl:ENSG00000140545 | Mfge8 or FDC-M1 |
CCR7 | GeneProduct | ensembl:ENSG00000126353 | Increased expression of the CCR7 receptor indicates the interaction of B cells with the antigens. In B cells that lack CCR7, antigen engagement fails to cause movement to the T zone. CCR7 interacts with the chemokines CCL19 and CCL21. |
EBI2 | GeneProduct | ensembl:ENSG00000169508 | EBI2 or GPR183 is highly expressed in B cells and is increased following their activation. EBI2 is required for the proper localization to inter- and outer-follicular niches of B cells following T-dependent antibody response. EBI2 is downregulated when B cells differentiate into GC cells. Lack of EBI2 correlates with reduced T-dependent antibody response. Differentiation between germinal center and extrafollicular-destined B cells occurs during this process of acivation through the expression of EBI2. Loss of EBI2 --> GC incorporation persistance of EBI2 receptor --> integration of activated B cell into EF pathway |
CCR7 | GeneProduct | ensembl:ENSG00000126353 | Reduction of CCR7 expression (along with increased expression of CXCR5) Th cells migrate to the T-B border, to aid in humoral response. |
ICOSL | GeneProduct | ensembl:ENSG00000160223 | ICOSL - inducible T-cell co-stimulator ligand, also known as ICOSLG When GC competition proceeds without ICOSL, selection of high-affinity variants in otherwise normal GC reactions is impaired. |
ICOSL | GeneProduct | ensembl:ENSG00000160223 | ICOSL - inducible T-cell co-stimulator ligand, also known as ICOSLG When GC competition proceeds without ICOSL, selection of high-affinity variants in otherwise normal GC reactions is impaired. |
CXCR4 | GeneProduct | ensembl:ENSG00000121966 | The increased expression of the chemokine receptor CXCR4 indicates that the B cell will enter the extrafollicular pathway. |
SELL | GeneProduct | ensembl:ENSG00000188404 | homing receptor CD62L (SELL) |
CXCR4 | GeneProduct | ensembl:ENSG00000121966 | CXCR4 is expressed by plasmablasts. It is assumed that CXCR4 is responisble for residing of the plasmablasts in the extrafollicular foci. Plasmablasts deficient in CXCR4 fail to migrate to normal sites of antibody. |
ISG15 | GeneProduct | ensembl:ENSG00000187608 | ISG15 acts as a chemoattractant for neutrophils. ISG15 is an autoimmune feature in autoimmune of memory-like B cells in SLE. |
IL-4 | GeneProduct | ensembl:ENSG00000113520 | IL6, IL4 and BAFF are predominantly produced by innate immune cells and promote B cell differentiation into plasmablasts. Dysregulation of B cells may therefore be caused by the innate response. |
CCR7 | GeneProduct | ensembl:ENSG00000126353 | Increased expression of the CCR7 receptor indicates the interaction of B cells with the antigens. CCR7 interacts with the chemokines CCL19 and CCL21 |
CXCL13 | Protein | uniprot:O43927 | |
IgM | Protein | uniprot:P0DOX6 | |
IL6 | Protein | uniprot:Q75MH2 | |
IgG | Protein | uniprot:P0DOX5 | |
CD1d | Protein | uniprot:P15813 | Antigen-presenting glycoprotein CD1d |
BTLA | Protein | uniprot:Q7Z6A9 | |
CD40L | Protein | uniprot:P29965 | tumor necrosis factor (TNF) family member |
IFN-γ | Protein | uniprot:P01579 | |
IL-21 | Protein | uniprot:Q9HBE4 | |
TNF-α | Protein | uniprot:P01375 | |
IL-21 | Protein | uniprot:Q9HBE4 | IL-21 promotes both EF and GC responses and is therefore considered to be a stimulator of B cell response. |
CD40L | Protein | uniprot:P29965 | |
IFN-α | Protein | uniprot:P48551 | |
SAP | Protein | uniprot:O60880 | |
TBX21 | Protein | uniprot:Q9UL17 | T-bet expression influences TFH, as a lack of T-bet correlates with increased frequency of TFH |
AID | Protein | uniprot:Q9GZX7 | activation-induced cytidine deaminase (AID) - enzyme required for both SHM and isotype switching. AID is expressed and active in non-GC proliferating B cells. |
Compl. C4-A | Protein | uniprot:P0C0L4 | |
Compl. C3 | Protein | uniprot:P01024 | Complement C3 |
IL-21 | Protein | uniprot:Q9HBE4 | IL21 stimulates DN2 B cell differentiation into PCs. |
N | Protein | uniprot:P0DTC9 | Nucleocapsid protein, N |
S | Protein | uniprot:P0DTC2 | Spike protein |
N | Protein | uniprot:P0DTC9 | Nucleocapsid protein, N |
References
- Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Förster R, et al. Nature. 2002 Mar 7;416(6876):94–9. PubMed Europe PMC Scholia
- Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Mol Cell Biol. 2002 Jul;22(13):4771–80. PubMed Europe PMC Scholia
- Extrafollicular antibody responses. MacLennan ICM, Toellner KM, Cunningham AF, Serre K, Sze DMY, Zúñiga E, et al. Immunol Rev. 2003 Aug;194:8–18. PubMed Europe PMC Scholia
- Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, et al. J Clin Invest. 2004 Dec;114(12):1800–11. PubMed Europe PMC Scholia
- Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Crotty S, Johnston RJ, Schoenberger SP. Nat Immunol. 2010 Feb;11(2):114–20. PubMed Europe PMC Scholia
- CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, et al. Nat Immunol. 2010 Apr;11(4):303–12. PubMed Europe PMC Scholia
- ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, Monticelli L, et al. Immunity. 2011 Jun 24;34(6):932–46. PubMed Europe PMC Scholia
- EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. Kelly LM, Pereira JP, Yi T, Xu Y, Cyster JG. J Immunol. 2011 Sep 15;187(6):3026–32. PubMed Europe PMC Scholia
- EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. Gatto D, Wood K, Brink R. J Immunol. 2011 Nov 1;187(9):4621–8. PubMed Europe PMC Scholia
- STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. Nurieva RI, Podd A, Chen Y, Alekseev AM, Yu M, Qi X, et al. J Biol Chem. 2012 Mar 30;287(14):11234–9. PubMed Europe PMC Scholia
- Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA. Immunity. 2012 Mar 23;36(3):374–87. PubMed Europe PMC Scholia
- New helping friends for B cells. Cerutti A, Puga I, Cols M. Eur J Immunol. 2012 Aug;42(8):1956–68. PubMed Europe PMC Scholia
- Activation of B cells by non-canonical helper signals. Cerutti A, Cols M, Puga I. EMBO Rep. 2012 Sep;13(9):798–810. PubMed Europe PMC Scholia
- Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Heesters BA, Chatterjee P, Kim YA, Gonzalez SF, Kuligowski MP, Kirchhausen T, et al. Immunity. 2013 Jun 27;38(6):1164–75. PubMed Europe PMC Scholia
- T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Liu D, Xu H, Shih C, Wan Z, Ma X, Ma W, et al. Nature. 2015 Jan 8;517(7533):214–8. PubMed Europe PMC Scholia
- Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Xu H, Chaudhri VK, Wu Z, Biliouris K, Dienger-Stambaugh K, Rochman Y, et al. Nat Immunol. 2015 Dec;16(12):1274–81. PubMed Europe PMC Scholia
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Immunity. 2018 Oct 16;49(4):725-739.e6. PubMed Europe PMC Scholia
- Extrafollicular responses in humans and SLE. Jenks SA, Cashman KS, Woodruff MC, Lee FEH, Sanz I. Immunol Rev. 2019 Mar;288(1):136–48. PubMed Europe PMC Scholia
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, et al. Nature. 2020 Aug;584(7821):437–42. PubMed Europe PMC Scholia
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. Nat Immunol. 2020 Dec;21(12):1506–16. PubMed Europe PMC Scholia
- Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. Elsner RA, Shlomchik MJ. Immunity. 2020 Dec 15;53(6):1136–50. PubMed Europe PMC Scholia
- Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity. Li Y, Li Z, Hu F. Clin Exp Immunol. 2021 Aug;205(2):119–27. PubMed Europe PMC Scholia
- Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. He B, Liu S, Wang Y, Xu M, Cai W, Liu J, et al. Signal Transduct Target Ther. 2021 May 17;6(1):195. PubMed Europe PMC Scholia
- Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19. Schultheiß C, Paschold L, Willscher E, Simnica D, Wöstemeier A, Muscate F, et al. iScience. 2021 Nov 19;24(11):103325. PubMed Europe PMC Scholia
- The role of B cells in COVID-19 infection and vaccination. Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, et al. Front Immunol. 2022 Aug 30;13:988536. PubMed Europe PMC Scholia